The investigator needs to assess causality for the headache. Was it caused by the study drug? By the ondansetron? By the omeprazole the participant started without telling anyone? By some interaction between all three? The answer depends entirely on the completeness of the concomitant medication record. If the coordinator documented only the ondansetron -- the medication the investigator prescribed -- the omeprazole is invisible to the safety analysis. The headache appears to have no pharmacological explanation other than the study drug. But headache is a known side effect of omeprazole. And headache is a known side effect of ondansetron. Without the complete medication picture, the causality assessment is being made with missing evidence, and it may be wrong.

This is not a hypothetical. I have seen this exact pattern -- participants self-medicating, coordinators documenting only prescribed treatments, and investigators making causality judgments on incomplete data -- more times than I care to count. Concomitant medication documentation in the context of safety reporting is not a clerical task. It is an evidentiary task. Every medication a participant takes during an adverse event becomes a variable in the causality equation, and a variable that is not documented is a variable that cannot be analyzed.

The investigator needs to assess causality for the headache. Was it caused by the study drug? By the ondansetron? By the omeprazole the participant started without telling anyone? By some interaction between all three? The answer depends entirely on the completeness of the concomitant medication record. If the coordinator documented only the ondansetron -- the medication the investigator prescribed -- the omeprazole is invisible to the safety analysis. The headache appears to have no pharmacological explanation other than the study drug. But headache is a known side effect of omeprazole. And headache is a known side effect of ondansetron. Without the complete medication picture, the causality assessment is being made with missing evidence, and it may be wrong.

This is not a hypothetical. I have seen this exact pattern -- participants self-medicating, coordinators documenting only prescribed treatments, and investigators making causality judgments on incomplete data -- more times than I care to count. Concomitant medication documentation in the context of safety reporting is not a clerical task. It is an evidentiary task. Every medication a participant takes during an adverse event becomes a variable in the causality equation, and a variable that is not documented is a variable that cannot be analyzed.